| For: | Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015; 21(14): 4323-4333 [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4323.htm |
| Number | Citing Articles |
| 1 |
Jessie Santoro, Lisa Agnello, Andrea Colacino, Ilaria Leone, Joel Verísimo-García, Eleonora Viscusi, Stefano Laudati, Giuseppe Iannaci, Antonio D’Antonio, África González-Fernández, Valentina De Falco, Immacolata Maietta. CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer. Translational Oncology 2026; 73 doi: 10.1016/j.tranon.2026.102993
|
| 2 |
Masaki Kuwatani, Hiroshi Kawakami, Yoshimasa Kubota, Kazumichi Kawakubo, Yoichi M. Ito, Shinji Togo, Takaaki Ikeda, Ken Kusama, Yuka Kobayashi, Teizo Murata, Naoya Sakamoto. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis. Pancreatology 2019; 19(4) doi: 10.1016/j.pan.2019.04.007
|
| 3 |
Yuhao Zhao, Mao Yang, Shijia Wang, Sk Jahir Abbas, Junzhe Zhang, Yongsheng Li, Rong Shao, Yingbin Liu. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854773
|
| 4 |
. 2017; doi: 10.70675/58257576zef53z49b3zb16bz3309b1154d62
|
| 5 |
Jingjing Liu, Lei Hu, Bi Zhou, Chungen Wu, Yingsheng Cheng. Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis. Translational Oncology 2022; 18 doi: 10.1016/j.tranon.2022.101357
|
| 6 |
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 2020; 12(11) doi: 10.3390/cancers12113234
|
| 7 |
Ishtiaq Hussain, Mamoon Ur Rashid, Jamaluddin Saeed, Zarghoona Wajid, Deepika Sarvepalli, Effa Zahid, Sundas Jehanzeb, Sarfraz Ahmad. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; doi: 10.1007/978-981-15-5471-1_14
|
| 8 |
Anelis Maria Marin, Michel Batista, Alexandre Luiz Korte de Azevedo, Talita Helen Bombardelli Gomig, Rodrigo Soares Caldeira Brant, Roger Chammas, Miyuki Uno, Diogo Dias Araújo, Dalila Luciola Zanette, Mateus Nóbrega Aoki. Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612604
|
| 9 |
Role of Biomarkers in Cancer Diagnosis and Therapeutics. 2026; doi: 10.1016/B978-0-443-44041-0.00025-8
|
| 10 |
Majdi A. Aljohani. Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation. Medicina 2025; 61(11) doi: 10.3390/medicina61111930
|
| 11 |
Hunter B. Moore, Rachel Culp-Hill, Julia A. Reisz, Peter J. Lawson, Angela Sauaia, Richard D. Schulick, Marco Del Chiaro, Trevor L. Nydam, Ernest E. Moore, Kirk C. Hansen, Angelo D'Alessandro. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. The American Journal of Surgery 2019; 218(6) doi: 10.1016/j.amjsurg.2019.08.015
|
| 12 |
Wei Wang, Li Chai, Naiyi Zhu, Qingrou Wang, Yiran Zhou, Weimin Chai. Clinical significance of pancreatic calcifications: a 15-year single-center observational study. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00725-9
|
| 13 |
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma. Nanoscale 2022; 14(9) doi: 10.1039/D1NR08394E
|
| 14 |
Haibo Xing, Jing Wang, Yanling Wang, Mengting Tong, Hong Hu, Changxin Huang, Da Li. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Gastroenterology Research and Practice 2018; 2018 doi: 10.1155/2018/8704751
|
| 15 |
Jiage Qian, Sebastiaan Ceuppens, Nikhil V. Tirukkovalur, Hong-Zhang He, Si-Yang Zheng, Rachel Suppok, Bas Groot Koerkamp, Amer H Zureikat, Alessandro Paniccia. Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 2026; doi: 10.1245/s10434-026-20413-w
|
| 16 |
Asmita Chopra, Hong-Zhang He, Jadranka Milosevic, Nikhil Tirukkovalur, Rudy El Asmar, Ibrahim Nassour, Geoffrey Nunns, Mingxi Chen, Jiaqi Chen, Siyu Jiang, Aatur D. Singhi, Anwaar Saeed, Janie Zhang, Kenneth Lee, Amer Zureikat, Si-Yang Zheng, Alessandro Paniccia. KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2026; 33(2) doi: 10.1245/s10434-025-18633-7
|
| 17 |
Jin-Hui Yi, Teng Wang, Ya-Wei Bi, Jin-Jie Xu, Miao Liu, Guang-Ming Chen, Zhao-Shen Li, Dan Wang, Ning-Li Chai, Liang-Hao Hu. A machine learning-based interpretable model for predicting pancreatic cancer in chronic pancreatitis patients with focal pancreatic lesions. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-16234-5
|
| 18 |
Bin Huang, Chang Xin, Huanjun Yan, Zhewei Yu.
A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures
. Critical Reviews in Immunology 2024; 44(3) doi: 10.1615/CritRevImmunol.2023051250
|
| 19 |
Boqiang Zhao, Boyue Zhao, Fangyao Chen. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2022; 34(9) doi: 10.1097/MEG.0000000000002415
|
| 20 |
Huimin Zhang, Wei Han, Meng Jin, Yamin Lai, Xi Wang, Jian Wang, Yao Yao, Dong Wu, Jiaming Qian, Hong Yang. Establishment and Verification of a Scoring Model for the Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis. Pancreas 2018; 47(4) doi: 10.1097/MPA.0000000000001029
|
| 21 |
Ville J. Sallinen, Helka Parviainen. Textbook of Pancreatic Cancer. 2021; doi: 10.1007/978-3-030-53786-9_32
|
| 22 |
Qi Zhang, Mao Ye, Cheng Lin, Manyi Hu, Yangyang Wang, Yu Lou, Quanming Kong, Jungang Zhang, Junjian Li, Yuhua Zhang, Tianxing Yang, Xu Sun, Weiyun Yao, Yongfei Hua, Haifeng Huang, Minghui Xu, Xiaoguang Wang, Xin Yu, Weifeng Tao, Runtian Liu, Yuming Gao, Tian Wang, Jianing Wang, Xiaobao Wei, Jiangchao Wu, Zhengping Yu, Chengwu Zhang, Chaohui Yu, Xueli Bai, Tingbo Liang. Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut 2023; 72(5) doi: 10.1136/gutjnl-2022-327496
|
| 23 |
Sung-Sik Han, Sang Myung Woo, Jun Hwa Lee, Joon Hee Kang, Sang-Jae Park, Woo Jin Lee, Hyeong Min Park, Jung Won Chun, Su Jung Kim, Hyun Ju Yoo, Kyung-Hee Kim, Soo-Youl Kim. Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC. Cancers 2025; 17(18) doi: 10.3390/cancers17182988
|
| 24 |
Francisco Carrillo-Perez, Octavio Caba, Cristina Jiménez-Luna, Francisco Ortuño, Daniel Castillo-Secilla, Luis Javier Herrera, Jose Prados, Ignacio Rojas. Machine learning identifies 6-gene signature in peripheral blood for pancreatic cancer diagnosis. Heliyon 2025; 11(12) doi: 10.1016/j.heliyon.2025.e43138
|
| 25 |
Yang Yang, Guangbing Li, Yu Zhang, Yunfeng Cui, Jun Liu. Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vascular Invasion. Journal of Clinical Medicine 2023; 12(8) doi: 10.3390/jcm12082769
|
| 26 |
Sujani M. K. Gamage, Chamath D. Ranaweera, Tracie T. Cheng, Sharmin Aktar, Vinod Gopalan, Farhadul Islam. Current Cancer Biomarkers. 2023; doi: 10.2174/9789815079364123010005
|
| 27 |
Sunil Badami, Htay Htay Kyi, Sunil Upadhaya, Samer Al Hadidi. Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed Diagnosis. Case Reports in Oncology 2017; 10(3) doi: 10.1159/000480076
|
| 28 |
Saranya Arumugam, C. Anjugam, R. Muthuvel, Gowtham Kumar Subbaraj. Epigenetic Regulations in Gastrointestinal Cancers. 2026; doi: 10.1016/B978-0-443-27765-8.00008-4
|
| 29 |
Zhe-Ying Wang, Xiao-Qing Ding, Hui Zhu, Rui-Xian Wang, Xiao-Rong Pan, Jian-Hua Tong. KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01295
|
| 30 |
Krzysztof Jakimów, Natalia Tekiela, Katarzyna Kozak, Robert Peterek, Anna Kwaśniewska, Jacek Pająk, Jerzy Chudek. Misdiagnosis Based on Neoplastic Markers—Extremely High Alpha-Fetoprotein in Patients with Intrahepatic Cholangiocarcinoma with Literature Review of the Published Cases. Medicina 2024; 60(7) doi: 10.3390/medicina60071109
|
| 31 |
Shuichi MITSUNAGA, Motohiro KOJIMA, Masafumi IKEDA, Atsushi OCHIAI. Serum microRNAs as tumor markers for diagnosis of pancreatic cancer. Suizo 2017; 32(1) doi: 10.2958/suizo.32.56
|
| 32 |
Xiaofei Fan, Jia Huang, Xiaohan Cai, Ayixie Maihemuti, Shu Li, Weili Fang, Bangmao Wang, Wentian Liu. Clinical value of the nomogram model based on endoscopic ultrasonography radiomics and clinical indicators in identifying benign and malignant lesions of the pancreas. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1504593
|
| 33 |
Min Seong Kim, Tae Joo Jeon, Ji Young Park, Jeongmin Choi, Won Chang Shin, Seong Eun Park, Ji-Young Seo, Young Moon Kim. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease. The Korean Journal of Gastroenterology 2017; 70(2) doi: 10.4166/kjg.2017.70.2.96
|
| 34 |
Yang Cheng, Kunyuan Wang, Lanlan Geng, Jingjing Sun, Wanfu Xu, Dingli Liu, Sitang Gong, Yun Zhu. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. EBioMedicine 2019; 40 doi: 10.1016/j.ebiom.2019.01.003
|
| 35 |
K. Passek, M. H. Bendels, D. Ohlendorf, E. Wanke, G. M. Oremek, D. A. Groneberg. Der Tumormarker CA 19-9. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2017; 67(6) doi: 10.1007/s40664-017-0211-3
|
| 36 |
Ding-Li Xu, Yi-Qun Wu, Chang Xin, Qi-Feng Zhou, Ming-Liang Chen, Huan-Jun Yan. Simple cholangitis induces extremely and recurrently elevated serum carbohydrate antigen 19-9 level. Hepatobiliary & Pancreatic Diseases International 2019; 18(3) doi: 10.1016/j.hbpd.2019.03.008
|
| 37 |
Di Wu, Zeng-Kan Du, Yuan-Chen Wang, Yi-Zhou Zheng, Hang-Ming Qi, Yu-Ru-Chen Zhu, Yu Cao, Lei Wang, Wen-Bin Zou, Zhuan Liao. Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis. Translational Oncology 2026; 65 doi: 10.1016/j.tranon.2026.102674
|
| 38 |
Jie Xia, Huarong Zhang, Qingzhou Guan, Shanshan Wang, Yawei Li, Jiajing Xie, Meifeng Li, Haiyan Huang, Haidan Yan, Ting Chen. Qualitative diagnostic signature for pancreatic ductal adenocarcinoma based on the within‐sample relative expression orderings. Journal of Gastroenterology and Hepatology 2021; 36(6) doi: 10.1111/jgh.15326
|
| 39 |
Weiwei Li, Jianli Wang, Yanhua Li, Qiuju Yue, Miaohang Cui, Jinlong Liu. KRAS Mutations in Peripheral Blood (with or without CA19-9) for Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis: a Systematic Review and Meta-analysis. Indian Journal of Surgery 2022; 84(4) doi: 10.1007/s12262-022-03475-4
|
| 40 |
Junhao Xie, Xianzhu Zhou, Rui Wang, Jiulong Zhao, Jian Tang, Qichen Zhang, Yiqi Du, Yanan Pang. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma. Medicine 2021; 100(23) doi: 10.1097/MD.0000000000026135
|
| 41 |
Jean-Marc Dumonceau, Myriam Delhaye, Nicolas Charette, Annarita Farina. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820927292
|
| 42 |
Go Eun Bae, Sang-Mi Kim, Jong Kyun Lee, Soo-Youn Lee. First large-scale prospective evaluation of serum S100A6 as a complementary biomarker for early pancreatic cancer detection. World Journal of Gastroenterology 2026; 32(21): 116581 doi: 10.3748/wjg.v32.i21.116581
Abstract(88) |
Core Tip(103) |
Full Article(HTML)(592)
|
Full Article (PDF)-2588K(40)
|
Full Article with Cover (PDF)-4165K(25)
|
Full Article (XML)-125K(25)
|
Audio-499K(5)
|
Peer-Review Report-322K(28)
|
Answering Reviewers-770K(75)
|
Supplementary Material-640K(29)
|
Times Cited (1)
|
Total Visits (803)
|
Open
|
| 43 |
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA Profiling for Diagnosis, Prognosis and Stratification of Cancer Treatment in Cholangiocarcinoma. Pharmacogenomics 2017; 18(14) doi: 10.2217/pgs-2017-0010
|
| 44 |
Kai Jia, Xia Zhao, Xueyi Dang. Mass spectrometry‑based iTRAQ analysis of serum markers in patients with pancreatic cancer. Oncology Letters 2020; doi: 10.3892/ol.2020.11491
|
| 45 |
Bishnupriya Chhatriya, Moumita Mukherjee, Sukanta Ray, Barsha Saha, Somdatta Lahiri, Sandip Halder, Indranil Ghosh, Sujan Khamrui, Kshaunish Das, Samsiddhi Bhattacharjee, Saroj Kant Mohapatra, Srikanta Goswami. Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02597-1
|
| 46 |
E. A. Dubtsova, L. V. Vinokurova, K. A. Nikolskaya, M. A. Kiryukova, D. S. Bordin. Chronic pancreatitis as a risk factor for pancreatic cancer (a clinical case). Almanac of Clinical Medicine 2018; 46(5) doi: 10.18786/2072-0505-2018-46-5-542-549
|
| 47 |
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, Ruzhual K Man, Amaresh Gogikar, Ankita Nanda, Lubna Mohammed. Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.44382
|
| 48 |
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, Chun-Chieh Yeh, Chao-Ming Tseng, Wen-Hsin Huang, Teng-Yu Lee, Chia-Shen Chu, Jaw-Town Lin. Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma. Journal of the Formosan Medical Association 2022; 121(12) doi: 10.1016/j.jfma.2022.07.003
|
| 49 |
Ömer BİNİCİER, Zehra PAKÖZ. Carbohydrate antigen 19-9 levels in early acute pancreatitis. Akademik Gastroenteroloji Dergisi 2019; 19(1) doi: 10.17941/agd.728662
|
| 50 |
Sven H Loosen, Ulf P Neumann, Christian Trautwein, Christoph Roderburg, Tom Luedde. Current and future biomarkers for pancreatic adenocarcinoma. Tumor Biology 2017; 39(6) doi: 10.1177/1010428317692231
|
| 51 |
Shuichi Mitsunaga, Masafumi Ikeda, Makoto Ueno, Satoshi Kobayashi, Masahiro Tsuda, Ikuya Miki, Takamichi Kuwahara, Kazuo Hara, Yukiko Takayama, Yutaro Matsunaga, Keiji Hanada, Akinori Shimizu, Hitoshi Yoshida, Tomohiro Nomoto, Kenji Takahashi, Hidetaka Iwamoto, Hideaki Iwama, Etsuro Hatano, Kohei Nakata, Masafumi Nakamura, Hiroko Sudo, Satoko Takizawa, Atsushi Ochiai. Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer. BMC Medicine 2025; 23(1) doi: 10.1186/s12916-025-03849-x
|
| 52 |
Estefania Roldan-Vasquez, Stephanie Cohen, Tara S. Kent. Diagnostic Dilemma. Surgical Oncology Clinics of North America 2026; 35(1) doi: 10.1016/j.soc.2025.05.004
|
| 53 |
David Sefrioui, France Blanchard, Emmanuel Toure, Paul Basile, Ludivine Beaussire, Claire Dolfus, Anne Perdrix, Marianne Paresy, Michel Antonietti, Isabelle Iwanicki-Caron, Raied Alhameedi, Stephane Lecleire, Alice Gangloff, Lilian Schwarz, Florian Clatot, Jean-Jacques Tuech, Thierry Frébourg, Fabrice Jardin, Jean-Christophe Sabourin, Nasrin Sarafan-Vasseur, Pierre Michel, Frédéric Di Fiore. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. British Journal of Cancer 2017; 117(7) doi: 10.1038/bjc.2017.250
|
| 54 |
O Joe Hines, Stephen J Pandol. Management of chronic pancreatitis. BMJ 2024; 384 doi: 10.1136/bmj-2023-070920
|
| 55 |
Koji Takao, Hiromitsu Maehira, Haruki Mori, Nobuhito Nitta, Takeru Maekawa, Katsushi Takebayashi, Masatsugu Kojima, Sachiko Kaida, Toru Miyake, Masaji Tani. A case of a pancreatic pseudocyst associated with alcoholic chronic pancreatitis that mimicked a mucinous cystic neoplasm. Clinical Journal of Gastroenterology 2026; doi: 10.1007/s12328-026-02409-x
|
| 56 |
Hongquan Qiu, Liang Zhang, Dongzhi Wang, Yu Zhang, Hongyu Cai, Haiyan Miao, Feihu Chu, Osamah Ibrahim Khalaf. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/4622877
|
| 57 |
Hiroto Matsui, Naoki Ikenaga, Masafumi Nakamura, Takaaki Tatsuguchi, Shingo Kozono, Hirohisa Okabe, Hiromitsu Hayashi, Tomohiko Adachi, Susumu Eguchi, Kazuaki Hashimoto, Toru Hisaka, Takao Ide, Hirokazu Noshiro, Teijiro Hirashita, Atsushi Miyoshi, Atsushi Nanashima, Masatoshi Kajiwara, Tomoharu Yoshizumi, Yasuhisa Mori, Hiroaki Nagano. Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospective Study. Annals of Gastroenterological Surgery 2026; 10(1) doi: 10.1002/ags3.70090
|
| 58 |
Jiaming Liu, Cong Wang, Zhen Chen, Qili Dai, Jingrui Bai, Yun‑Feng Cui. Analysis of risk factors related to acute exacerbation in patients with chronic pancreatitis: a retrospective study of 313 cases from a single center in China. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03528-w
|
| 59 |
Zhicheng Yi, Fanhua Zhou, Xinkai Zhao. The relationship between serum CA50, CA242, and SAA levels and clinical pathological characteristics and prognosis in patients with pancreatic cancer. Open Medicine 2025; 20(1) doi: 10.1515/med-2025-1304
|
| 60 |
G.G. Varvanina, K.A. Lesko, D.S. Bordin, E.A. Dubtsova, M.V. Malykh, K.K. Noskova, L.V. Vinokurova. Blood biomarkers and computed tomography for differential diagnosis of pancreatic cancer and chronic pancreatitis. Dokazatel'naya gastroenterologiya 2021; 10(4) doi: 10.17116/dokgastro20211004112
|